118 related articles for article (PubMed ID: 21512047)
21. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
22. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
[TBL] [Abstract][Full Text] [Related]
24. [18F]Fluorodeoxyglucose positron emission tomography surveillance of hepatic metastases from prostate cancer following radiofrequency ablation: a case report.
Ludwig V; Hopper OW; Martin WH; Kikkawa R; Delbeke D
Am Surg; 2003 Jul; 69(7):593-8. PubMed ID: 12889623
[TBL] [Abstract][Full Text] [Related]
25. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
Vandenbroucke F; Vandemeulebroucke J; Ilsen B; Verdries D; Belsack D; Everaert H; Buls N; Ros PR; de Mey J
J Vasc Interv Radiol; 2014 Aug; 25(8):1240-9. PubMed ID: 24954606
[TBL] [Abstract][Full Text] [Related]
27. Liver metastases: 3D shape-based analysis of CT scans for detection of local recurrence after radiofrequency ablation.
Bricault I; Kikinis R; Morrison PR; Vansonnenberg E; Tuncali K; Silverman SG
Radiology; 2006 Oct; 241(1):243-50. PubMed ID: 16928977
[TBL] [Abstract][Full Text] [Related]
28. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
29. Role of B-mode ultrasound screening in detection of local tumor recurrence in the first year after radiofrequency ablation in the liver.
Eisele RM; Schumacher G; Lopez-Hänninen E; Neuhaus P
Cancer Detect Prev; 2007; 31(4):316-22. PubMed ID: 17935909
[TBL] [Abstract][Full Text] [Related]
30. Quantitative color mapping of the arterial enhancement fraction in patients with diffuse liver disease.
Kang SE; Lee JM; Klotz E; Kim KW; Kim JH; Han JK; Choi BI
AJR Am J Roentgenol; 2011 Oct; 197(4):876-83. PubMed ID: 21940575
[TBL] [Abstract][Full Text] [Related]
31. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor.
Yamanaka T; Takaki H; Nakatsuka A; Uraki J; Fujimori M; Hasegawa T; Sakuma H; Yamakado K
J Vasc Interv Radiol; 2013 Mar; 24(3):341-6. PubMed ID: 23352855
[TBL] [Abstract][Full Text] [Related]
32. Factors limiting complete tumor ablation by radiofrequency ablation.
Paulet E; Aubé C; Pessaux P; Lebigot J; Lhermitte E; Oberti F; Ponthieux A; Calès P; Ridereau-Zins C; Pereira PL
Cardiovasc Intervent Radiol; 2008; 31(1):107-15. PubMed ID: 17968620
[TBL] [Abstract][Full Text] [Related]
33. Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful?
Liu ZY; Chang ZH; Lu ZM; Guo QY
Chin Med J (Engl); 2010 Jul; 123(13):1690-4. PubMed ID: 20819630
[TBL] [Abstract][Full Text] [Related]
34. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
[TBL] [Abstract][Full Text] [Related]
35. FDG-PET for detecting local tumor recurrence of ablated liver metastases: a diagnostic meta-analysis.
Poulou LS; Ziakas PD; Ziogas DC; Doxani C; Xyla V; Vakrinos G; Voulgarelis M; Thanos L
Biomarkers; 2012 Sep; 17(6):532-8. PubMed ID: 22712479
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
37. Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience.
Kuehl H; Stattaus J; Hertel S; Hunold P; Kaiser G; Bockisch A; Forsting M
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):234-40. PubMed ID: 18155453
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography.
Shiozawa K; Watanabe M; Takayama R; Takahashi M; Wakui N; Iida K; Sumino Y
J Clin Ultrasound; 2010 May; 38(4):182-9. PubMed ID: 20232404
[TBL] [Abstract][Full Text] [Related]
39. Clinical scenarios associated with local recurrence after laparoscopic radiofrequency thermal ablation of colorectal liver metastases.
Aksoy E; Aliyev S; Taskin HE; Birsen O; Mitchell J; Siperstein A; Berber E
Surgery; 2013 Oct; 154(4):748-52; discussion 752-4. PubMed ID: 24074411
[TBL] [Abstract][Full Text] [Related]
40. Local tumor progression after radiofrequency ablation of colorectal liver metastases: evaluation of ablative margin and three-dimensional volumetric analysis.
Frich L; Hagen G; Brabrand K; Edwin B; Mathisen O; Aaløkken TM; Gladhaug IP
J Vasc Interv Radiol; 2007 Sep; 18(9):1134-40. PubMed ID: 17804776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
